Sweden: Vitrolife appoints Tolf as new CFO

Patrik Tolf has been appointed CFO of Vitrolife, a biotechnology company that develops products to counter fertility issues in humans, effective January 1, 2022. Tolf is currently interim CFO at Karolinska University Hospital. He has previously held senior finance positions within Volvo Car Group and Saab. “We are pleased to welcome Tolf to Vitrolife and…

You must be a HMI Subscriber to view this content.

Subscribe Now »